| Domain |
Quality Indicator |
Facility |
State |
Facility rank
(#1 is best) |
| For the Quality Indicators below, a lower percentage is better. |
| Psychosocial |
Worsening or serious resident behavior problems (LS) |
17.6% |
8.4% |
303 of
326 |
| Psychosocial |
Prevalence of depressive symptoms (LS) |
2.4% |
4.1% |
137 of
325 |
| Quality of Life |
Prevalence of physical restraints (LS) |
0.0% |
0.0% |
1 of
326 |
| Continence |
Worsening or serious bowel incontinence (LS) |
49.2% |
30.5% |
317 of
326 |
| Continence |
Worsening or serious bladder incontinence (LS) |
37.1% |
29.9% |
237 of
326 |
| Continence |
Prevalence of occasional to full bowel incontinence without a toileting plan (LS) |
100.0% |
93.9% |
161 of
314 |
| Continence |
Prevalence of occasional to full bladder incontinence without a toileting plan (LS) |
81.0% |
84.8% |
68 of
318 |
| Continence |
Prevalence of indwelling catheter (LS) |
0.0% |
2.3% |
1 of
326 |
| Infections |
Prevalence of urinary tract infections (LS) |
1.9% |
2.9% |
129 of
326 |
| Infections |
Prevalence of infections (LS) |
4.1% |
2.4% |
265 of
324 |
| Accidents |
Percent of residents experiencing one or more falls with major injury (LS) |
0.0% |
0.7% |
1 of
326 |
| Nutrition |
Prevalence of unexplained weight loss (LS) |
3.0% |
4.3% |
119 of
326 |
| Skin Care |
Prevalence of pressure sores in high risk residents (LS) |
8.0% |
5.1% |
281 of
322 |
| Psychotropics |
Prevalence of anti-psychotics without a diagnosis of psychosis (LS) |
5.8% |
9.0% |
122 of
321 |
| Functioning |
Worsening or serious functional dependence (LS) |
n/a |
|
n/a of
0 |
| Functioning |
Worsening or serious mobility dependence (LS) |
n/a |
|
n/a of
0 |
| Functioning |
Worsening or serious range of motion limitation (LS) |
20.9% |
13.2% |
266 of
323 |
| Pain |
Percent of residents who self-report moderate to severe pain (LS) |
8.6% |
14.7% |
87 of
325 |
| For the Quality Indicators below, a higher percentage is better. |
| Functioning |
Walking as well or better than on a previous assessment (LS) |
n/a |
|
n/a of
0 |
| (Date range:
October 1, 2023 to September 30, 2024) |
Contact Us
